Altogether, these different controls verified CD49d and TMEM119 as specific makers for MDM or microglia in the GBM microenvironment and thereby confirmed that models for primary or relapsing GBM differ in phagocyte composition. This evidence concerns the gene ITGA4 and glioblastoma.